Epoch Investment Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-530,434
Closed -$14.7M 407
2024
Q1
$14.7M Buy
530,434
+113,587
+27% +$2.52M 0.07% 218
2023
Q4
$8.03M Sell
416,847
-48,080
-10% -$871K 0.04% 273
2023
Q3
$7.51M Sell
464,927
-285,765
-38% -$5.07M 0.05% 272
2023
Q2
$14.3M Buy
750,692
+2,322
+0.3% +$41.4K 0.08% 224
2023
Q1
$10.9M Buy
748,370
+132,948
+22% +$2.38M 0.06% 266
2022
Q4
$12M Sell
615,422
-241,220
-28% -$4.7M 0.07% 252
2022
Q3
$20.6M Buy
856,642
+65,520
+8% +$2.02M 0.13% 192
2022
Q2
$24.9M Sell
791,122
-49,075
-6% -$1.78M 0.15% 189
2022
Q1
$37M Sell
840,197
-52,382
-6% -$2.25M 0.18% 159
2021
Q4
$38.8M Buy
892,579
+83,808
+10% +$3.29M 0.2% 156
2021
Q3
$25.3M Buy
808,771
+429,657
+113% +$16.9M 0.14% 182
2021
Q2
$16M Buy
379,114
+20,033
+6% +$779K 0.09% 207
2021
Q1
$13.5M Buy
359,081
+35,863
+11% +$1.12M 0.06% 222
2020
Q4
$8.74M Buy
+323,218
New +$8.31M 0.04% 244

Other funds holding ACH

Epoch Investment Partners's ACH Position: Q2 2024 in Review

Epoch Investment Partners sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 530,434 shares — an estimated $14.7M sold.

Epoch Investment Partners first reported a position in ACH in Q4 2020 and held it in 14 quarters. The position peaked at $38.8M in Q4 2021. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.

  • Epoch Investment Partners reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
  • Epoch Investment Partners sold 530,434 Accendra Health shares in Q2 2024, an estimated $14.7M.
  • Epoch Investment Partners first reported a position in Accendra Health in Q4 2020 and held it in 14 quarters.
  • Epoch Investment Partners's Accendra Health position peaked at $38.8M in Q4 2021.
  • 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.

Based on Epoch Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.